Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis Burmester, G., Fiore, S., Hu, C., Fay, J., Lee, E., Genovese, M. J RHEUMATOL PUBL CO. 2018: 1035

View details for Web of Science ID 000438512300204